ETHI

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

iShares S&P 500 Etf

IVV

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

Betashares Nasdaq 100 Etf

NDQ

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

Change Financial Limited

CCA

Change Financial Ltd. engages in the provision of mobile digital banking. The company is headquartered in Brisbane, Queensland. The company went IPO on 2016-06-30. The Company’s technology provides tailored payment solutions, card issuing, and testing to banks and fintech. Its technology is used by approximately 157 clients across 41 countries to deliver simple, flexible and fast-to-market payment services, including card issuing and testing. Its payments as a service (PaaS) platform, Vertexon, integrates with banks and fintech's core systems, enabling the delivery of digital and virtual card solutions to their customers. The company includes integrated features, such as Apple Pay, Google Pay, Samsung Pay and Buy Now Pay Later (BNPL) services. The company manages and processes approximately 27 million credit, debit and prepaid cards worldwide. PaySim enables banks and fintech to complete end-to-end testing of their payment platforms and processes from a desktop. The firm also provides the default standard for testing for many Australian companies.

Imagion Biosystems Limited

IBX

Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The Company’s principal activity consists of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using superparamagnetic relaxometry. The firm operates through Research and Development segment. Its MagSense technology is a functional imaging agent for detecting cancers and other critical diseases. MagSense technology uses bio-safe magnetic nanoparticles that are cancer-specific. MagSense nanoparticles are specially formulated as an injectable solution for each type of cancer. MagSense applications include breast cancer, prostate cancer, and ovarian cancer. The firm is conducting a Phase I clinical study of its MagSense HER2 imaging agent. Its PrecisionMRX nanoparticles have been developed for magnetic relaxometry and other demanding biomedical applications. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.